These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32758183)

  • 1. Antagonists of the serotonin receptor 5A target human breast tumor initiating cells.
    Gwynne WD; Shakeel MS; Girgis-Gabardo A; Kim KH; Ford E; Dvorkin-Gheva A; Aarts C; Isaac M; Al-Awar R; Hassell JA
    BMC Cancer; 2020 Aug; 20(1):724. PubMed ID: 32758183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts.
    Gwynne WD; Hallett RM; Girgis-Gabardo A; Bojovic B; Dvorkin-Gheva A; Aarts C; Dias K; Bane A; Hassell JA
    Oncotarget; 2017 May; 8(19):32101-32116. PubMed ID: 28404880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase-A activity is required for clonal tumorsphere formation by human breast tumor cells.
    Gwynne WD; Shakeel MS; Wu J; Hallett RM; Girgis-Gabardo A; Dvorkin-Gheva A; Hassell JA
    Cell Mol Biol Lett; 2019; 24():59. PubMed ID: 31754354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer.
    Hallett RM; Girgis-Gabardo A; Gwynne WD; Giacomelli AO; Bisson JN; Jensen JE; Dvorkin-Gheva A; Hassell JA
    Oncotarget; 2016 Aug; 7(33):53137-53152. PubMed ID: 27447971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
    Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
    PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASP5736, a novel 5-HT5A receptor antagonist, ameliorates positive symptoms and cognitive impairment in animal models of schizophrenia.
    Yamazaki M; Harada K; Yamamoto N; Yarimizu J; Okabe M; Shimada T; Ni K; Matsuoka N
    Eur Neuropsychopharmacol; 2014 Oct; 24(10):1698-708. PubMed ID: 25108314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Serotonin in Breast Cancer Stem Cells.
    Gwynne WD; Shakeel MS; Girgis-Gabardo A; Hassell JA
    Molecules; 2021 May; 26(11):. PubMed ID: 34073226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4'-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain.
    Thomas DR; Soffin EM; Roberts C; Kew JN; de la Flor RM; Dawson LA; Fry VA; Coggon SA; Faedo S; Hayes PD; Corbett DF; Davies CH; Hagan JJ
    Neuropharmacology; 2006 Sep; 51(3):566-77. PubMed ID: 16846620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation.
    Fang DD; Zhang CC; Gu Y; Jani JP; Cao J; Tsaparikos K; Yuan J; Thiel M; Jackson-Fisher A; Zong Q; Lappin PB; Hayashi T; Schwab RB; Wong A; John-Baptiste A; Bagrodia S; Los G; Bender S; Christensen J; Vanarsdale T
    PLoS One; 2013; 8(6):e67258. PubMed ID: 23826249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective AKT Inhibition by MK-2206 Represses Colorectal Cancer-Initiating Stem Cells.
    Malkomes P; Lunger I; Luetticke A; Oppermann E; Haetscher N; Serve H; Holzer K; Bechstein WO; Rieger MA
    Ann Surg Oncol; 2016 Sep; 23(9):2849-57. PubMed ID: 27059026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR/Notch Antagonists Enhance the Response to Inhibitors of the PI3K-Akt Pathway by Decreasing Tumor-Initiating Cell Frequency.
    Fu W; Lei C; Yu Y; Liu S; Li T; Lin F; Fan X; Shen Y; Ding M; Tang Y; Ye X; Yang Y; Hu S
    Clin Cancer Res; 2019 May; 25(9):2835-2847. PubMed ID: 30670492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 5-HT5A receptor antagonists ameliorate scopolamine-induced working memory deficit in mice and reference memory impairment in aged rats.
    Yamazaki M; Okabe M; Yamamoto N; Yarimizu J; Harada K
    J Pharmacol Sci; 2015 Mar; 127(3):362-9. PubMed ID: 25837935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice.
    Parris AB; Zhao Q; Howard EW; Zhao M; Ma Z; Yang X
    J Exp Clin Cancer Res; 2017 Feb; 36(1):28. PubMed ID: 28193239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer.
    Dillon LM; Bean JR; Yang W; Shee K; Symonds LK; Balko JM; McDonald WH; Liu S; Gonzalez-Angulo AM; Mills GB; Arteaga CL; Miller TW
    Oncogene; 2015 Jul; 34(30):3968-76. PubMed ID: 25284585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression.
    Kassai F; Schlumberger C; Kedves R; Pietraszek M; Jatzke C; Lendvai B; Gyertyán I; Danysz W
    Behav Pharmacol; 2012 Aug; 23(4):397-406. PubMed ID: 22785385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GR-127935-sensitive mechanism mediating hypotension in anesthetized rats: are 5-HT5B receptors involved?
    Sánchez-Maldonado C; López-Sánchez P; Anguiano-Robledo L; Leopoldo M; Lacivita E; Terrón JA
    J Cardiovasc Pharmacol; 2015 Apr; 65(4):335-41. PubMed ID: 25502305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
    Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
    Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers.
    Coussy F; El Botty R; Lavigne M; Gu C; Fuhrmann L; Briaux A; de Koning L; Dahmani A; Montaudon E; Morisset L; Huguet L; Sourd L; Painsec P; Chateau-Joubert S; Larcher T; Vacher S; Melaabi S; Salomon AV; Marangoni E; Bieche I
    J Hematol Oncol; 2020 Feb; 13(1):13. PubMed ID: 32087759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.
    Korkaya H; Paulson A; Iovino F; Wicha MS
    Oncogene; 2008 Oct; 27(47):6120-30. PubMed ID: 18591932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.